In-cosmetics Global 2026 live: Lubrizol eye-peptide targets 7 tissues, including ligaments and muscles
Key takeaways
- Lubrizol unveils an eye care peptide targeting seven soft tissues, including muscles and ligaments, at In-cosmetics Global 2026.
- Oilkemia 7S polymer and Arbalon RC-76 focus on texture, stability, and sustainable formulation performance.
- The company is expanding its global testing capabilities for better efficacy across diverse skin types.

Lubrizol is presenting a set of new ingredients that combine performance with sustainability, and highlights how digital tools like AI are shaping its R&D strategies, at the ongoing In-cosmetics Global 2026 trade show this week (April 14–16).
One of the key highlights is Eyeseryl All-In peptide, an updated version of the chemical manufacturer’s existing eye care ingredient, but with expanded benefits.
Personal Care Insights speaks with Dorota Niemczycka, senior global marketing and communications manager at Lubrizol, live from the show floor in Paris, France. She tells us that the peptide was developed with AI-assisted screening and boasts targeting skin layers that conventional cosmetic ingredients do not.
“It targets seven different key soft tissues in the eye area. So you’re starting from the epidermis, the dermis, adipose tissue, lymphatic and vascular systems — but what’s unique is that it also reaches the muscle and ligament tissues. As far as we know, there’s no other ingredient on the market that claims to work on ligaments and muscles,” Niemczycka says.
The Eyeseryl All-In peptide is designed to address multiple signs of fatigue and aging at once, such as dark circles, puffiness, wrinkles, and sagging. According to Niemczycka, by targeting all the different layers of skin tissue, the ingredient provides more holistic care benefits.
“In some of the images from the clinical studies, after seven days, we already saw very good results for dark circles, eye bags, crow’s feet wrinkles, and even droopy eyelids,” she explains.
Versatile thickener
Another solution the company is launching is Oilkemia 7S polymer, a biodegradable rheology modifier designed for oil-based formulations. It helps thicken and stabilize formulas while claiming to maintain a smooth, non-tacky feel.
The ingredient also improves clarity and suspension, which helps to ensure that pigments and particles in formulas remain evenly distributed.
Its versatility allows it to be used across skin care, sun care, makeup, hair care, and cleansing applications, while supporting more sustainable formulation design. Lubrizol is taking home an award for the ingredient after being awarded one in the Makeup Bar category.
Lubrizol is unveiling an eye care peptide that targets seven soft tissues, including muscles and ligaments, at In-cosmetics Global 2026.“So far, we’ve got really good feedback from clients, with a lot of interest in starting to test this product,” Niemczycka reports.
Cellulose for surfactant systems
Lubrizol is also introducing Arbalon RC-76, a cellulose-derived rheology modifier produced through fermentation. The ingredient was designed mainly for hair care and cleansing formulations, and it provides thickening, suspension, and clarity in surfactant-based systems.
“It also has a very sustainable profile, is biodegradable, and is derived from fermentation,” says Niemczycka.
The ingredient claims to enhance formulae’s sensory performance and helps improve the deposition of conditioning agents in products such as shampoos and conditioners.
Diverse testing
Lubrizol maintains that testing its ingredients on a diverse group of subjects allows it to better verify the efficacy.
“We use our internal User Research Institute to carry out the testing. It’s an internal capability where we run clinical testing on volunteers. When we launch a product, we want to make sure that it works, and the more types of skin you can test it on, the better,” says Niemczycka.
“Originally, for several years, we had one [research] center in Barcelona, Spain. But last year we opened another one in Shanghai, China, for the Asian region, and just months ago we opened a new one in São Paulo, Brazil,” Niemczycka adds, noting that Lubrizol has plans to expand its testing capabilities with an Indian location scheduled for 2027.
She says the Eyeseryl All-In peptide was tested across different ethnicities, genders, and of Asian and Caucasian origin.
“The idea of having different centers around the world is really to be closer to those regions, for local development, but also to be able to offer products that have efficacy tested across different types of skin,” Niemczycka concludes.
With live reporting by Ela Jade Ünal at In-cosmetics Global 2026 in Paris, France.













